Back to calendar
Fate Therapeutics, Inc. (FATE) Earnings
FATE reports earnings on Wednesday, August 5, 2026
earnings report
August 5, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.27
Actual EPS: $-0.26
Company overview
Market Cap$324.0M
SectorHealth Technology
IndustryBiotechnology